Truist upgraded pain therapy developer Pacira BioSciences (NASDAQ:PCRX) to Hold from Sell on Thursday, noting that the ...
Truist Securities adjusted its outlook on Manpower Inc . (NYSE:MAN), reducing the staffing company's price target from $74.00 to $70.00. Despite this change, the firm maintained its Hold rating on the ...
Influence Media Partners (“Influence Media” or “Influence”) — a leading music and entertainment company focused on partnering with and investing in to ...
Money from the program will be used by nonprofit groups to help rebuild small businesses, housing and infrastructure in 39 ...
Net interest margin, which measures lending profitability, expanded to 3.07%, compared with 2.95% a year earlier. Truist's ...
Truist Securities analyst Jake Bartlett reiterated a Buy rating on the shares of Sysco Corp (NYSE:SYY) and lowered the price ...
Truist Financial's Q4 beat EPS and revenue estimates, but noninterest expenses rose and specific lending segments faced ...
Leaders at the bank, which has been operating in DFW for more than a decade, want to capitalize on positive trends.
Truist Financial analyst Youssef Squali maintained a Buy rating on Cimpress (CMPR – Research Report) today. The company’s shares closed ...
In a report released today, Pete Osterland from Truist Financial initiated coverage with a Buy rating on TRONOX (TROX – Research Report) and a ...
Truist Financial Corp. continued to settle into its trimmer fee-income strategy during the fourth quarter by slightly ...